The use of AI in biotechnology is changing faster than the rules governing either technology
The recent announcement of novel, viable viruses created by artificial intelligence showcases the rapid advancements in biotechnology.
The recent announcement of novel, viable viruses created by artificial intelligence showcases the rapid advancements in biotechnology.

The article discusses how biotechnology students can build careers through research and innovation.
The article highlights advancements in CRISPR technology and its impact on drug discovery.
The article discusses how generative biology is transforming the process of drug discovery.
Scientists have identified genes that block the success of gene therapy applications.
Epicrispr Biotechnologies recently closed a $90 million Series C financing round.

The article explores a platform that utilizes AI for drug discovery aimed at combating aging by designing new molecules.
Researchers at Northwestern have created a new nanostructure designed to improve gene therapy effectiveness.
A molecular electromagnetic sensor may enable remote-controlled gene therapy.
Biotech startups in the U.S., France, and China are racing to bring new gene therapy treatments to market for deafness.

Daphne Koller discusses using AI to enhance drug discovery processes.

The article discusses the CRISPR technique used for gene-editing.
The article discusses the ethical concerns surrounding gene therapy, illustrated by a case in China that highlights potential dangers.
The Leber Congenital Amaurosis market is experiencing advancements due to breakthrough gene therapy innovations.
The research journal examines the advancements in CRISPR technology facilitated by artificial intelligence.

The article discusses the growth and potential of the AI in genomics market influenced by advancements in precision medicine and drug discovery.
Advances in AI-designed base editors are explored as a significant development for next-generation gene therapy.

Artificial intelligence is reshaping pharmaceutical research and the discovery of new therapies.
Researchers at Dongguk University have developed an innovative gene switch that is controllable via electromagnetic fields.

The article explores the debates among aging researchers regarding the effects of rapamycin on longevity.
The article highlights a platform using AI to connect epigenetic data with practical longevity protocols.
The article discusses an innovative AI architecture aimed at enhancing drug discovery.
The article discusses the current state and future prospects of AI in drug discovery.
Georgia State biology professor Eric Gaucher discusses how CRISPR technology can bring back an ancient gene that prevents gout and fatty liver.
This article lists the 50 best-funded biotech companies of 2026.
Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial safety.
The article reviews the role of AI in drug discovery, highlighting both its capabilities and limitations.
Insilico Medicine is utilizing AI technology to enhance and accelerate the drug discovery process.
The latest developments in longevity biotechnology are discussed at a major research event.
The study introduces InVirtuoGen, a framework for drug discovery that focuses on fragment-based approaches.

The article describes a validation architecture on AWS for cell and gene therapy involving CAR-T technology.
The genome engineering market is projected to grow significantly due to advancements in CRISPR and gene editing technologies.
The article presents a new genetic tool that aids researchers in understanding the logic of gene regulation in the human genome.
Researchers in Madison have identified a new species of endangered baobab tree in Madagascar through genetic analysis.
A joint research team has developed an oral nanomedicine that enhances cancer immunotherapy by utilizing metabolites produced by gut bacteria.
Companies like Insilico Medicine and Ro5 are advancing longevity science through human trial data beyond traditional mouse model studies.
A review discusses how AI, CRISPR, and mRNA technologies are driving significant advancements in biotechnology.
Researchers found that adding three specific amino acids to lipid nanoparticles can significantly enhance the efficacy of mRNA therapy.
The article discusses the risks and opportunities associated with synthetic biology and human genome editing technologies.
Researchers have developed a DNA rotor that allows for tracking gene transcription at a very detailed level.
The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a novel drug class.
This article explores the use of Rust in bioinformatics through static analysis-guided AI translation.
This article discusses the use of genome-wide CRISPR screens to investigate human T cells in solid tumors.
The article presents a method for generative antibody design that is conditioned on antigens, leveraging advanced design methodologies.

The article reports on an AI that autonomously conducted an experiment to find a drug, highlighting advancements in AI in medicine.
The acellular therapy market size has grown rapidly in recent years.
The Pharmalittle newsletter discusses Moderna's mRNA flu shot approval and a death related to a gene-editing trial in China.
A research team has uncovered a potential gene-control mechanism involving histone acetylation sites that reshape DNA condensates.

The article discusses how AI is revolutionizing drug development and clinical trials.
Describe what you care about in plain English. MyFeed scans thousands of sources and delivers only what matters to you.
Popular feeds